Hiroaki Nanba

2.5k total citations
51 papers, 2.0k citations indexed

About

Hiroaki Nanba is a scholar working on Pharmacology, Molecular Biology and Plant Science. According to data from OpenAlex, Hiroaki Nanba has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 15 papers in Molecular Biology and 13 papers in Plant Science. Recurrent topics in Hiroaki Nanba's work include Fungal Biology and Applications (32 papers), Polysaccharides and Plant Cell Walls (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hiroaki Nanba is often cited by papers focused on Fungal Biology and Applications (32 papers), Polysaccharides and Plant Cell Walls (10 papers) and Pharmacological Effects of Natural Compounds (6 papers). Hiroaki Nanba collaborates with scholars based in Japan, Australia and Italy. Hiroaki Nanba's co-authors include Noriko Kodama, HISATORA KURODA, Yuki Masuda, Kiyoshi Komuta, Kazumi Kubo, Keiko Kubo, Morichika Konishi, Kyoko Adachi, Shigeto Mizuno and Norio Sakai and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

Hiroaki Nanba

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Nanba Japan 29 1.3k 743 552 421 414 51 2.0k
Qingjiu Tang China 26 1.1k 0.9× 1.1k 1.5× 529 1.0× 301 0.7× 246 0.6× 89 2.0k
Dong Ki Park South Korea 24 502 0.4× 322 0.4× 460 0.8× 253 0.6× 240 0.6× 57 1.6k
Trần Hồng Quang Vietnam 28 524 0.4× 597 0.8× 1.2k 2.1× 277 0.7× 335 0.8× 173 2.3k
Jamal Mahajna Israel 20 676 0.5× 523 0.7× 591 1.1× 245 0.6× 270 0.7× 57 1.7k
Liyan Song China 29 836 0.6× 1.2k 1.7× 972 1.8× 222 0.5× 228 0.6× 93 2.5k
Rongmin Yu China 32 997 0.8× 1.4k 1.8× 1.3k 2.3× 274 0.7× 252 0.6× 127 3.0k
Sundar Rao Koyyalamudi Australia 16 503 0.4× 696 0.9× 527 1.0× 279 0.7× 242 0.6× 29 1.8k
Eock Kee Hong South Korea 21 606 0.5× 573 0.8× 384 0.7× 164 0.4× 134 0.3× 42 1.2k
Tetsuro Ikekawa Japan 22 760 0.6× 406 0.5× 518 0.9× 223 0.5× 175 0.4× 65 1.3k
Keishiro Shimura Japan 17 569 0.4× 395 0.5× 274 0.5× 163 0.4× 138 0.3× 36 922

Countries citing papers authored by Hiroaki Nanba

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Nanba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nanba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nanba more than expected).

Fields of papers citing papers by Hiroaki Nanba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nanba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nanba. The network helps show where Hiroaki Nanba may publish in the future.

Co-authorship network of co-authors of Hiroaki Nanba

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nanba. A scholar is included among the top collaborators of Hiroaki Nanba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nanba. Hiroaki Nanba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodama, Noriko, Shigeto Mizuno, Hiroaki Nanba, & Naoaki Saito. (2010). Potential Antitumor Activity of a Low-Molecular-Weight Protein Fraction from Grifola frondosa Through Enhancement of Cytokine Production. Journal of Medicinal Food. 13(1). 20–30. 16 indexed citations
2.
Asakawa, Akihiro, Mineko Fujimiya, Akira Niijima, et al.. (2010). Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3. Psychoneuroendocrinology. 35(8). 1178–1186. 19 indexed citations
3.
Ito, Koichi, et al.. (2009). Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression. International Immunopharmacology. 9(10). 1189–1196. 27 indexed citations
4.
Masuda, Yuki, et al.. (2009). Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice. International Immunopharmacology. 9(5). 620–626. 57 indexed citations
5.
Masuda, Yuki, Akihisa Matsumoto, Toshihiko Toida, et al.. (2009). Characterization and Antitumor Effect of a Novel Polysaccharide from Grifola frondosa. Journal of Agricultural and Food Chemistry. 57(21). 10143–10149. 53 indexed citations
6.
Kodama, Noriko, et al.. (2004). Administration of a Polysaccharide from Grifola frondosa Stimulates Immune Function of Normal Mice. Journal of Medicinal Food. 7(2). 141–145. 44 indexed citations
7.
Kodama, Noriko, Kiyoshi Komuta, & Hiroaki Nanba. (2003). Effect of Maitake ( Grifola frondosa ) D-Fraction on the Activation of NK Cells in Cancer Patients. Journal of Medicinal Food. 6(4). 371–377. 106 indexed citations
8.
Kodama, Noriko, et al.. (2003). Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Letters. 192(2). 181–187. 40 indexed citations
9.
Kodama, Noriko, et al.. (2002). A Polysaccharide, Extract From Grifola frondosa, Induces Th-1 Dominant Responses in Carcinoma-Bearing BALB/c Mice. The Japanese Journal of Pharmacology. 90(4). 357–360. 55 indexed citations
10.
Kodama, Noriko, Kiyoshi Komuta, Norio Sakai, & Hiroaki Nanba. (2002). Effects of D-Fraction, a Polysaccharide from Grifola frondosa on Tumor Growth Involve Activation of NK Cells.. Biological and Pharmaceutical Bulletin. 25(12). 1647–1650. 100 indexed citations
11.
Kodama, Noriko, et al.. (2001). Addition of Maitake D-fraction Reduces the Effective Dosage of Vancomycin for the Treatment of Listeria-Infected Mice. The Japanese Journal of Pharmacology. 87(4). 327–332. 32 indexed citations
12.
Matsui, Ken, Noriko Kodama, & Hiroaki Nanba. (2001). Effects of Maitake ( Grifola frondosa ) D-Fraction on the carcinoma angiogenesis. Cancer Letters. 172(2). 193–198. 22 indexed citations
13.
Kodama, Noriko, et al.. (2000). Effects of Maitake (Grifola frondosa) Polysaccharide on Collagen-Induced Arthritis in Mice. The Japanese Journal of Pharmacology. 84(3). 293–300. 34 indexed citations
14.
Nanba, Hiroaki. (1997). MAITAKE D-FRACTION : HEALING AND PREVENTIVE POTENTIAL FOR CANCER. 12(1). 43–49. 23 indexed citations
15.
Nanba, Hiroaki & Keiko Kubo. (1997). Effect of Maitake D‐Fraction on Cancer Prevention. Annals of the New York Academy of Sciences. 833(1). 204–207. 27 indexed citations
16.
Kubo, Keiko & Hiroaki Nanba. (1997). Anti-hyperliposis Effect of Maitake Fruit Body (Grifola frondosa). I.. Biological and Pharmaceutical Bulletin. 20(7). 781–785. 54 indexed citations
17.
Nanba, Hiroaki. (1995). Activity of Maitake D‐fraction to Inhibit Carcinogenesis and Metastasis. Annals of the New York Academy of Sciences. 768(1). 243–245. 26 indexed citations
18.
Kubo, Kazumi, et al.. (1994). Anti-diabetic Activity Present in the Fruit Body of Grifola frondosa (Maitake). I.. Biological and Pharmaceutical Bulletin. 17(8). 1106–1110. 104 indexed citations
19.
Nanba, Hiroaki & HISATORA KURODA. (1987). Potentiating effect of .BETA.-glucan from Cochliobolus miyabeanus on host-mediated antitumor activity in mice.. Chemical and Pharmaceutical Bulletin. 35(3). 1289–1293. 4 indexed citations
20.
Nanba, Hiroaki & HISATORA KURODA. (1987). Potentiation of host-mediated antitumor activity by a .BETA.-glucan derived from mycelia of Cochliobolus miyabeanus.. Chemical and Pharmaceutical Bulletin. 35(4). 1523–1530. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingjiu Tang Breakdown of academic impact, for papers by Dong Ki Park Breakdown of academic impact, for papers by Trần Hồng Quang Breakdown of academic impact, for papers by Jamal Mahajna Breakdown of academic impact, for papers by Liyan Song Breakdown of academic impact, for papers by Rongmin Yu Breakdown of academic impact, for papers by Sundar Rao Koyyalamudi Breakdown of academic impact, for papers by Eock Kee Hong Breakdown of academic impact, for papers by Tetsuro Ikekawa Breakdown of academic impact, for papers by Keishiro Shimura
Rankless by CCL
2026